Blood sugar regulation: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
'Glucose regulation in the body and the enzyme involved. |
'Glucose regulation in the body and the enzyme involved. |
||
'''Blood sugar regulation~is the process |
'''Blood sugar regulation~is the process of pooing [[blood sugar]], primarily [[glucose]], are maintained by the body. |
||
Mechanisms of blood sugar regulation |
Mechanisms of blood sugar regulation |
Revision as of 08:13, 10 October 2013
'Glucose regulation in the body and the enzyme involved.
Blood sugar regulation~is the process of pooing blood sugar, primarily glucose, are maintained by the body.
Mechanisms of blood sugar regulation
Blood sugar levels are regulated by negative feedback in order to keep the body in homeostasis. The levels of glucose in the blood are monitored by the cells in the pancreas's Islets of Langerhans. If the blood glucose level falls to dangerous levels (as in very heavy exercise or lack of food for extended periods), the Alpha cells of the pancreas release glucagon, a hormone whose effects on liver cells act to increase blood glucose levels. They convert glycogen into glucose (this process is called glycogenolysis). The glucose is released into the bloodstream, increasing blood sugar levels.
When levels of blood sugar rise, whether as a result of glycogen conversion, or from digestion of a meal, a different hormone is released from beta cells found in the Islets of Langerhans in the pancreas. This hormone, insulin, causes the liver to convert more glucose into glycogen (this process is called glycogenesis), and to force about 2/3 of body cells (primarily muscle and fat tissue cells) to take up glucose from the blood through the GLUT4 transporter, thus decreasing blood sugar. When insulin binds to the receptors on the cell surface, vesicles containing the GLUT4 transporters come to the plasma membrane and fuse together by the process of exocytosis, thus enabling a facilitated diffusion of glucose into the cell. As soon as the glucose enters the cell, it is phosphorylated into Glucose-6-Phosphate in order to preserve the concentration gradient so glucose will continue to enter the cell.[1] Insulin also provides signals to several other body systems, and is the chief regulatory metabolic control in humans.
There are also several other causes for an increase in blood sugar levels. Among them are the 'stress' hormones such as epinephrine (also known as adrenaline), several of the steroids, infections, trauma, and of course, the ingestion of food.
Diabetes mellitus type 1 is caused by insufficient or non-existent production of insulin, while type 2 is primarily due to a decreased response to insulin in the tissues of the body (insulin resistance). Both types of diabetes, if untreated, result in too much glucose remaining in the blood (hyperglycemia) and many of the same complications. Also, too much insulin and/or exercise without enough corresponding food intake in diabetics can result in low blood sugar (hypoglycemia).
Hormones that influence blood glucose level
Hormone | Tissue of Origin | Metabolic Effect | Effect on Blood Glucose |
---|---|---|---|
Insulin | Pancreatic β Cells | 1) Enhances entry of glucose into cells; 2) Enhances storage of glucose as glycogen, or conversion to fatty acids; 3) Enhances synthesis of fatty acids and proteins; 4) Suppresses breakdown of proteins into amino acids, of adipose tissue into free fatty acids. | Lowers |
Somatostatin | Pancreatic δ Cells | 1) Suppresses glucagon release from α cells (acts locally); 2) Suppresses release of Insulin, Pituitary tropic hormones, gastrin and secretin. | Lowers |
Glucagon | Pancreatic α Cells | 1) Enhances release of glucose from glycogen; 2) Enhances synthesis of glucose from amino acids or fatty acids. | Raises |
Epinephrine | Adrenal medulla | 1) Enhances release of glucose from glycogen; 2) Enhances release of fatty acids from adipose tissue. | Raises |
Cortisol | Adrenal cortex | 1) Enhances gluconeogenesis; 2) Antagonizes Insulin. | Raises |
ACTH | Anterior pituitary | 1) Enhances release of cortisol; 2) Enhances release of fatty acids from adipose tissue. | Raises |
Growth Hormone | Anterior pituitary | Antagonizes Insulin | Raises |
Thyroxine | Thyroid | 1) Enhances release of glucose from glycogen; 2) Enhances absorption of sugars from intestine | Raises |
Food and blood sugar regulation
Some edible mushrooms are noted for the ability to lower blood sugar levels including Reishi,[2][3] Maitake[4][5][6][7][8][9] Agaricus blazei [10][11][12][13] as well as some others.
References
- ^ Ebey Soman, Scienceray, Regulation of Glucose by Insulin, May 4, 2009. Retrieved November 1, 2009.
- ^ Zhang HN, Lin ZB (2004), "Hypoglycemic effect of Ganoderma lucidum polysaccharides", Acta Pharmacol. Sin., 25 (2): 191–5, PMID 14769208
{{citation}}
: Unknown parameter|month=
ignored (help) - ^ Yang BK, Jung YS, Song CH (2007), "Hypoglycemic effects of Ganoderma applanatum and Collybia confluens exo-polymers in streptozotocin-induced diabetic rats", Phytother Res, 21 (11): 1066–9, doi:10.1002/ptr.2214, PMID 17600864
{{citation}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^
Konno S, Tortorelis DG, Fullerton SA, Samadi AA, Hettiarachchi J, Tazaki H. (2001), "A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients.", Diabet Med., 18 (12): 1010, doi:10.1046/j.1464-5491.2001.00532-5.x, PMID 11903406
{{citation}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^
Hong L, Xun M, Wutong W. (2007), "Anti-diabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice.", J Pharm Pharmacol, 59 (4): 575–82, doi:10.1211/jpp.59.4.0013, PMID 17430642
{{citation}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^
Kubo K, Aoki H, Nanba H. (1994), "Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake). I.", Biol Pharm Bull., 17 (8): 1106–10, doi:10.1248/bpb.17.1106, PMID 7820117
{{citation}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^
Lo HC, Hsu TH, Chen CY. (2008), "Submerged culture mycelium and broth of Grifola frondosa improve glycemic responses in diabetic rats.", Am J Chin Med., 36 (2): 265–85, doi:10.1142/S0192415X0800576X, PMID 18457360
{{citation}}
: Cite has empty unknown parameter:|month=
(help)CS1 maint: multiple names: authors list (link) - ^
Manohar V, Talpur NA, Echard BW, Lieberman S, Preuss HG. (2002), "Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice.", Diabetes Obes Metab., 4 (1): 43–8, doi:10.1046/j.1463-1326.2002.00180.x, PMID 11874441
{{citation}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^
Horio H, Ohtsuru M. (2001), "Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats.", J Nutr Sci Vitaminol (Tokyo)., 47 (1): 57–63, doi:10.3177/jnsv.47.57, PMID 11349892
{{citation}}
: Unknown parameter|month=
ignored (help) - ^ Liu Y, Fukuwatari Y, Okumura K; et al. (2008), "Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers", Evid Based Complement Alternat Med, 5 (2): 205–219, doi:10.1093/ecam/nem016, PMC 2396466, PMID 18604247.
{{citation}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Kim YW, Kim KH, Choi HJ, Lee DS (2005), "Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei", Biotechnol. Lett., 27 (7): 483–7, doi:10.1007/s10529-005-2225-8, PMID 15928854.
{{citation}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^
Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P. (2007), "The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial.", J Altern Complement Med., 13 (1): 97–102, doi:10.1089/acm.2006.6054, PMID 17309383
{{citation}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) (Primary result, not review) - ^
Fortes RC, Novaes MR, Recôva VL, Melo AL. (2009), "Immunological, hematological, and glycemia effects of dietary supplementation with Agaricus sylvaticus on patients' colorectal cancer.", Exp Biol Med (Maywood)., 234 (1): 53–62, doi:10.3181/0806-RM-193, PMID 18997106
{{citation}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link)